Exploration of Baicalin analogues against main Protease involved in Covid-19 as potential inhibitors involving in silico approaches
The proteolytic enzymesinvolved in the processing and replication of coronavirus serve a promising drug targetsfor coronavirus. Although a few numbers of vaccines have been made available, there is a great need for effective treatment to manageit. The current study involved the exploration of baical...
Main Authors: | Sharma Pratibha, Singh Manjinder, Kaur Paranjeet, Silakari Pragati, Mujawar Somdutt, Kumar Sahu Sanjeev |
---|---|
Format: | Article |
Language: | English |
Published: |
EDP Sciences
2024-01-01
|
Series: | BIO Web of Conferences |
Online Access: | https://www.bio-conferences.org/articles/bioconf/pdf/2024/05/bioconf_rtbs2024_01036.pdf |
Similar Items
-
Investigating Holistic Natural Strategies for The Management of Huntington's Disease
by: Silakari Pragati, et al.
Published: (2024-01-01) -
Discovery of C-12 dithiocarbamate andrographolide analogues as inhibitors of SARS-CoV-2 main protease: In vitro and in silico studies
by: Bodee Nutho, et al.
Published: (2022-01-01) -
An in-silico investigation of potential natural polyphenols for the targeting of COVID main protease inhibitor
by: Nada H. Aljarba, et al.
Published: (2022-10-01) -
Scaffold Morphing and In Silico Design of Potential BACE-1 (β-Secretase) Inhibitors: A Hope for a Newer Dawn in Anti-Alzheimer Therapeutics
by: Shiveena Bhatia, et al.
Published: (2023-08-01) -
Identification of possible SARS-CoV-2 main protease inhibitors: in silico molecular docking and dynamic simulation studies
by: Aniruddhya Mukherjee, et al.
Published: (2023-07-01)